Viewing data from:

PENTOLAIR

ANDA

CYCLOPENTOLATE HYDROCHLORIDE | A040075 | BAUSCH AND LOMB INC

1 strength0 unique patents0 unique exclusivities

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-07-15 | 2 NDCs

Highest NADAC/Unit

$2.20

per ml

Lowest NADAC/Unit

$0.8645

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
24208073501CYCLOPENTOLATE 1% EYE DROPS	$2.20	ML	Generic	—	2026-06-17
24208073506CYCLOPENTOLATE 1% EYE DROP	$0.8645	ML	Generic	—	2026-06-17

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

VA Federal Supply Schedule

Government-negotiated contract prices | 2 NDCs (2 FSS)

Lowest Price

$11.86

Highest Price

$27.78

FSS NDCs

Big4 NDCs

Description	Price	Type	Vendor	Contract End
24208-0735-01CYCLOPENTOLATE HCL 1% SOLN,OPH	$11.86	FSS	Golden State Medical Supply, Inc.	06/14/2028
24208-0735-06CYCLOPENTOLATE HCL 1% SOLN,OPH	$27.78	FSS	Golden State Medical Supply, Inc.	06/14/2028

Source: VA Federal Supply Schedule (va.gov). Prices are government-negotiated contract prices.

API Supply Chain2 active DMFs1 inactive

2 active API suppliers hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

ESTEVE QUIMICA SACYCLOPENTOLATE HYDROCHLORIDE

DMF 72721987

C-SQUARED PHARMA LTDCYCLOPENTOLATE HYDROCHLORIDE

DMF 363422021

PHARMECO LABORATORIES INCInactiveCYCLOPENTOLATE HYDROCHLORIDE (P-637)

DMF 67591986

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Products (1)

#001 — 1%

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Apr 29, 1994

No patent or exclusivity listings for this strength.